
    
      Primary aim of annual rate of cognitive decline. Secondary aims will be addressed in sub-set
      of participants: 1) among participants, African-American race (African-Americans have high
      risk of Vitamin D deficiency) modifies effects of vitamin D3 supplementation on cognitive
      decline; 2) among a subset of participants, baseline plasma levels of vitamin D and omega-3
      fatty acids modify agent effects.
    
  